3D Printing Medical Devices Global Markets Report 2024-2029 Featuring 3D Systems, Carbon, Cellink, Eos, Fabrx, Formlabs, GE, HP, Materialise, Nikon, Prodways, Proto Labs, Regenhu, Renishaw, Stratasys
Proto Labs, Inc. (NYSE:PRLB) Is Largely Controlled by Institutional Shareholders Who Own 86% of the Company
Proto Labs Launches Axtra3D HPS Technology to Boost Capabilities
Protolabs Expands 3D Printing Options With Hybrid PhotoSynthesis Technology
After a Year of 0.9% Returns, Proto Labs, Inc.'s (NYSE:PRLB) Share Price Drop Last Week May Have Less of an Impact on Institutional Investors
Is Proto Labs, Inc.'s (NYSE:PRLB) Stock Price Struggling As A Result Of Its Mixed Financials?
Protolabs to Attend the Gateway Conference on September 4th
Proto Labs, Inc. (PRLB) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
LPG: Industrial demand is expected to remain high, and the expected import volume in August is at a high level.
Looking at August, the demand for deep processing still maintains above 4.4 million tons, but there is limited imported-to-domestic arbitrage space, and currently high import costs will constrain the trend of import volume growth to the port.
Why Is Proto Labs, Inc. (PRLB) Among the Best 3D Printing and Additive Manufacturing Stocks To Buy Right Now?
Proto Labs' (NYSE:PRLB) Solid Earnings Are Supported By Other Strong Factors
Is Proto Labs, Inc.'s (NYSE:PRLB) Recent Price Movement Underpinned By Its Weak Fundamentals?
Needham Reiterates Hold on Proto Labs
Proto Labs Analyst Ratings
Is Proto Labs, Inc. (NYSE:PRLB) Potentially Undervalued?
Earnings Call Summary | Proto Labs(PRLB.US) Q2 2024 Earnings Conference
Proto Labs | 10-Q: Q2 2024 Earnings Report
Needham Maintains Proto Labs(PRLB.US) With Hold Rating
Needham analyst James Ricchiuti maintains $Proto Labs(PRLB.US)$ with a hold rating.According to TipRanks data, the analyst has a success rate of 56.5% and a total average return of 16.4% over the
Proto Labs: Hold Rating With Cautious Outlook Amid Q3 Guidance Concerns and Macroeconomic Challenges
Express News | Proto Labs, Inc. : Craig-Hallum Cuts Target Price to $30 From $34